Form 4: Inari Medical Principal Accounting Officer Receives Stock Award
SEC Form 4 Filing
Inari Medical's Principal Accounting Officer, Karen Silva, was granted 9,215 restricted stock units (RSUs) that will vest quarterly starting January 1, 2025.
Summary
- Karen Silva, the Principal Accounting Officer at Inari Medical, Inc., received 9,215 restricted stock units (RSUs) on December 1, 2024.
- These RSUs will begin vesting on January 1, 2025.
- The vesting schedule is set at 1/16th of the RSUs vesting each quarter, contingent on continued service through each vesting date.
Sentiment
Score: 7
Explanation: The document reflects a standard practice of equity compensation, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.
Positives
- The grant of RSUs to a key officer like the Principal Accounting Officer aligns their interests with the company's long-term performance.
- The vesting schedule encourages continued service and commitment from the officer.
Risks
- The vesting of the RSUs is contingent on continued service, which could be a risk if the officer were to leave the company before all units vest.
Future Outlook
The RSUs will vest over time, contingent on continued service, aligning the officer's interests with the company's long-term performance.
Industry Context
Stock-based compensation is a common practice in the biotech and medical device industry to attract and retain key talent. This grant is consistent with that trend.
Comparison to Industry Standards
- Many companies in the medical device sector use restricted stock units as part of their compensation packages.
- The vesting schedule of 1/16th quarterly is a fairly standard approach to incentivizing long-term commitment.
- Companies like Medtronic and Boston Scientific also use similar equity-based compensation strategies for their executives.
Stakeholder Impact
- Shareholders may view this positively as it aligns management's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Next Steps
- The RSUs will vest quarterly starting January 1, 2025, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 12/01/2024 | Date of the RSU grant to Karen Silva. |
| 01/01/2025 | Vesting commencement date for the granted RSUs. |
| 12/03/2024 | Date of the filing of the SEC Form 4. |
Keywords
restricted stock units, RSUs, stock award, equity compensation, insider trading, Inari Medical, Karen Silva, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.